A major real-world study by University of California, Irvine pharmacy researchers has found serious blood-related side effects associated with antibody-drug conjugates, an increasingly important class of targeted cancer therapies. ...
Jun 2, 2026
0
6
The U.S. Food and Drug Administration has approved Taiho Oncology's Inqovi (decitabine and cedazuridine) plus venetoclax for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are 75 years or older ...
May 25, 2026
0
5
For patients with breast cancer, administration of pegfilgrastim 72 hours postchemotherapy reduces pegfilgrastim-induced bone pain (PIBP) compared with administration at 24 and 48 hours, according to a study published online ...
Mar 24, 2026
0
2
For a child battling cancer, an unexpectedly high temperature can initiate a race against time to reach providers who can treat and monitor symptoms. And for families in low- and middle-income communities in Mexico, pediatric ...
Jan 28, 2025
0
17
Treatment with a molecule known as A485 can quickly and temporarily increase levels of white blood cells, a critical part of the body's immune system, an effect that is difficult to deliver with currently available pharmaceuticals, ...
Jan 31, 2024
0
35
New research published in Clinical & Translational Immunology has identified the child cancer patients at greatest risk of developing life-threatening infections, a crucial step towards the development of an early diagnostic ...
Jul 12, 2022
0
42
